Dr. Dong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2006 - 2009
Harbin Medical UniversityClass of 1997
Certifications & Licensure
WA State Medical License 2012 - 2026
OR State Medical License 2024 - 2025
TX State Medical License 2010 - 2018- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsClinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-worl...Yu-Ce Wei, Wei-Xin Liu, Fei Qi, Chang-Gong Zhang, Bao-Min Zheng
Annals of Hematology. 2024-01-01 - 2 citationsComparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.Fei Qi, Yan Xie, Dedao Wang, Yue Chai, Bo Chen
Annals of Hematology. 2022-09-01 - 9 citationsFirst-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell...Yue Chai, Bo Chen, Fei Qi, Hui Fang, Shu-Nan Qi
International Journal of Radiation Oncology, Biology, Physics. 2022-07-15
Press Mentions
- The Long Noncoding RNA ANRIL Promotes Cell Apoptosis in Lipopolysaccharide-Induced Acute Kidney Injury Mediated by the TLR4/Nuclear Factor-Kappa B PathwayFebruary 18th, 2020
- A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive PatientsJanuary 16th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
